Recent Advances of Respiratory Infections, Second Edition

A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Medical Microbiology".

Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 1301

Special Issue Editors


E-Mail Website
Guest Editor
Department of Respiratory Medicine, Kyorin University School of Medicine, Mitaka, Japan
Interests: diagnostic methods for pleural effusion; lung sounds; Mycoplasma pneumoiae; pneumonia; respiratory viruses
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Pediatrics, Laboratory of Pediatrics, Erasmus MC-Sophia Children’s Hospital, University Medical Centre Rotterdam, Rotterdam, The Netherlands
Interests: host-pathogen interactions; antigen presenting cells; pediatric respiratory infections; Mycoplasmas; M. pneumoniae
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Pediatrics, Leader of Infection Control Team, Kawasaki Medical School, Kurashiki, Japan
Interests: multidrug-resistant pathogens; antimicrobial therapy; pneumonia
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue is a continuation of our previous Special Issue, “Recent Advances of Respiratory Infections”.

In this COVID-19 era, diagnostic methods and/or techniques for respiratory infections have been developed. However, these advanced methods, in turn, attract lots of attention for the principles or clinical pitfalls of handling patients with respiratory infections. In this Special Issue of Microorganisms, we invite you to submit contributions concerning any aspects related to respiratory infections, including respiratory viruses, bacteria, and fungi. In addition, we also welcome original research, review papers or case reports describing host–pathogen interactions (i.e., translational research), antimicrobial resistance, and virulence factors of pathogens in respiratory tract infections.

Dr. Takeshi Saraya
Dr. Wendy Unger
Dr. Tomohiro Oishi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • respiratory viruses
  • fungus
  • bacteria
  • respiratory tract infection
  • Mycoplasma pneumoniae
  • clinical and critical pitfalls

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

9 pages, 1033 KiB  
Communication
Co-Circulation of SARS-CoV-2 and Other Respiratory Pathogens in Upper and Lower Respiratory Tracts during Influenza Season 2022–2023 in Lazio Region
by Licia Bordi, Antonella Vulcano, Giuseppe Sberna, Marino Nonis, Paolo Giacomini, Fabrizio Maggi, Carla Fontana and Eleonora Lalle
Microorganisms 2023, 11(9), 2239; https://doi.org/10.3390/microorganisms11092239 - 5 Sep 2023
Cited by 1 | Viewed by 1125
Abstract
Lower respiratory tract infections (LRTIs) occur when there is a lower airway tract infection. They are well-known for increasing the susceptibility of patients to bacterial/fungal co-infections and super-infections. In this study, we present the results of our investigation, which involved 381 consecutive patients [...] Read more.
Lower respiratory tract infections (LRTIs) occur when there is a lower airway tract infection. They are well-known for increasing the susceptibility of patients to bacterial/fungal co-infections and super-infections. In this study, we present the results of our investigation, which involved 381 consecutive patients admitted to our hospital during the Influenza season from October 2022 to April 2023. Among the 381 specimens, 75 were bronchoalveolar (BAL), and 306 were nasopharyngeal swabs (NPSs). Notably, 34.4% of the examined samples tested positive for SARS-CoV-2. Of these, we observed that 7.96% of NPSs showed positivity only for other respiratory viruses, while a substantial percentage (77%) of BAL specimens exhibited positive results only for bacterial co-infections. The results of our study not only confirm the importance of co-infections in COVID-19 but also emphasize the significance of utilizing rapid diagnostic tests (RDTs) for the timely diagnosis of LRTIs. In fact, RDTs allow for the identification of multiple pathogens, providing clinicians with useful and timely information to establish effective therapy. Full article
(This article belongs to the Special Issue Recent Advances of Respiratory Infections, Second Edition)
Show Figures

Figure 1

Back to TopTop